Literature DB >> 34541083

Generation of Mutant Pigs by Direct Pronuclear Microinjection of CRISPR/Cas9 Plasmid Vectors.

Chin-Kai Chuang1, Ching-Fu Tu1, Chien-Hong Chen1,2.   

Abstract

A set of Cas9 and single guide CRISPR RNA expression vectors was constructed. Only a very simple procedure was needed to prepare specific single-guide RNA expression vectors with high target accuracy. Since the de novo zygotic transcription had been detected in mouse embryo at the 1-cell stage, the plasmid DNA vectors encoding Cas9 and GGTA1 gene specific single-guide RNAs were micro-injected into zygotic pronuclei to confirm such phenomenon in 1-cell pig embryo. Our results demonstrated that mutations caused by these CRISPR/Cas9 plasmids occurred before and at the 2-cell stage of pig embryos, indicating that besides the cytoplasmic microinjection of in vitro transcribed RNA, the pronuclear microinjection of CRISPR/Cas9 DNA vectors provided an efficient solution to generate gene-knockout pig.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  CRISPR/Cas9; GGTA1; Pronuclear microinjection

Year:  2017        PMID: 34541083      PMCID: PMC8410424          DOI: 10.21769/BioProtoc.2321

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  38 in total

Review 1.  CRISPR-Cas Systems in Prokaryotes.

Authors:  Michał Burmistrz; Krzysztof Pyrć
Journal:  Pol J Microbiol       Date:  2015

2.  Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes.

Authors:  Jose L Estrada; Greg Martens; Ping Li; Andrew Adams; Kenneth A Newell; Mandy L Ford; James R Butler; Richard Sidner; Matt Tector; Joseph Tector
Journal:  Xenotransplantation       Date:  2015-03-01       Impact factor: 3.907

3.  Endogenous transcription occurs at the 1-cell stage in the mouse embryo.

Authors:  C Bouniol; E Nguyen; P Debey
Journal:  Exp Cell Res       Date:  1995-05       Impact factor: 3.905

4.  Blastocyst complementation generates exogenic pancreas in vivo in apancreatic cloned pigs.

Authors:  Hitomi Matsunari; Hiroshi Nagashima; Masahito Watanabe; Kazuhiro Umeyama; Kazuaki Nakano; Masaki Nagaya; Toshihiro Kobayashi; Tomoyuki Yamaguchi; Ryo Sumazaki; Leonard A Herzenberg; Hiromitsu Nakauchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

Review 5.  Adaptation in CRISPR-Cas Systems.

Authors:  Samuel H Sternberg; Hagen Richter; Emmanuelle Charpentier; Udi Qimron
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

6.  Generation of rat pancreas in mouse by interspecific blastocyst injection of pluripotent stem cells.

Authors:  Toshihiro Kobayashi; Tomoyuki Yamaguchi; Sanae Hamanaka; Megumi Kato-Itoh; Yuji Yamazaki; Makoto Ibata; Hideyuki Sato; Youn-Su Lee; Jo-Ichi Usui; A S Knisely; Masumi Hirabayashi; Hiromitsu Nakauchi
Journal:  Cell       Date:  2010-09-03       Impact factor: 41.582

7.  Reporter gene expression in G2 of the 1-cell mouse embryo.

Authors:  P T Ram; R M Schultz
Journal:  Dev Biol       Date:  1993-04       Impact factor: 3.582

8.  Generation of kidney from pluripotent stem cells via blastocyst complementation.

Authors:  Jo-ichi Usui; Toshihiro Kobayashi; Tomoyuki Yamaguchi; A S Knisely; Ryuichi Nishinakamura; Hiromitsu Nakauchi
Journal:  Am J Pathol       Date:  2012-04-14       Impact factor: 4.307

9.  Generation of B cell-deficient pigs by highly efficient CRISPR/Cas9-mediated gene targeting.

Authors:  Fengjiao Chen; Ying Wang; Yilin Yuan; Wei Zhang; Zijian Ren; Yong Jin; Xiaorui Liu; Qiang Xiong; Qin Chen; Manling Zhang; Xiaokang Li; Lihua Zhao; Ze Li; Zhaoqiang Wu; Yanfei Zhang; Feifei Hu; Juan Huang; Rongfeng Li; Yifan Dai
Journal:  J Genet Genomics       Date:  2015-05-27       Impact factor: 4.275

10.  Short motif sequences determine the targets of the prokaryotic CRISPR defence system.

Authors:  F J M Mojica; C Díez-Villaseñor; J García-Martínez; C Almendros
Journal:  Microbiology       Date:  2009-03       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.